Is BioSyntech Inc halal to invest in?

According to Musaffa's Shariah screening methodology, BioSyntech Inc (BSYI) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is BioSyntech Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BioSyntech Inc using these criteria to determine its compliance status.

Can Muslims buy shares of BioSyntech Inc?

Muslim investors may consider investing in BioSyntech Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is BioSyntech Inc classified as NOT COVERED?

Musaffa determines the Shariah status of BioSyntech Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for BioSyntech Inc updated?

The Shariah compliance status of BioSyntech Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like BioSyntech Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of BioSyntech Inc?

You can check the latest Shariah compliance status of BioSyntech Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BioSyntech Inc. Stock Analysis BSYI

United States Health Care Nano Cap

BioSyntech, Inc. Engages in the development of bio-therapeutic thermogels designed for tissue repair and delivery of therapeutic agents. The company is headquartered in Laval, Quebec and currently employs 20 full-time employees. The company went IPO on 2000-01-10. The firm is developing biotherapeutic thermogels for regenerative medicine (tissue repair) and therapeutic delivery. The firm's platform technology is a family of hydrogels called BST-Gel, some of which are liquid at low temperature and solid at human body temperature. These gels can be injected or applied to a specific local site and offers properties for the local repair of damaged tissue such as cartilage, bone and chronic wounds and provide the benefit of avoiding invasive surgery. The firm's lead, late-stage product, BST-CarGel is undergoing an international pivotal trial.

Financial Metrics & Statements of BioSyntech Inc (BSYI)

FAQ's for BioSyntech Inc (BSYI)

According to Musaffa’s Shariah screening methodology, BioSyntech Inc (BSYI) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.